How Rodent and NHP Models Support COVID-19 Treatment Development, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss how different animal models can be used to assess a large number of clinical, biological, virological and immunological parameters of SARS-CoV-2. Prophylactic and therapeutic strategies can also be evaluated, depending on each product-specific mode of action.

Choosing the right animal model might be challenging, based on various modes of action and/or timing of action of the tested molecules.

Preclinical validation of an extended portfolio of prophylactic and therapeutic options against SARS-CoV-2-induced pathologies remains a major challenge for the scientific and medical community. In this context, the high value of several animal models of SARS-CoV-2 infection has been demonstrated to screen a variety of products, such as vaccines, biologics or small molecules (repurposed drugs and new chemical entities). Still, choosing the right animal model might be challenging, based on various modes of action and/or timing of action of the tested molecules.

In this webinar, our guest presenters will discuss several case studies to illustrate the features of rodent (golden Syrian hamster, human AC2-expressing mice) and nonhuman primate (NHP) models, which provide different pathology settings (moderate vs. severe COVID-19). These examples will help the attendees in their decision process regarding valid COVID-19 model selection. In all of these experimental models, prophylactic and therapeutic strategies can be evaluated, depending on each product-specific mode of action.

Register for this webinar to learn how to select the most appropriate COVID-19 animal model for preclinical studies.

Join Nicolas Legrand, PhD, In Vivo Lab & Study Unit Director, Oncodesign and Roger Le Grand, PhD, Director, CEA IDMIT, for the live webinar on Tuesday, November 16, 2021 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit How Rodent and NHP Models Support COVID-19 Treatment Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website